Invention Grant
- Patent Title: Compounds
-
Application No.: US16321742Application Date: 2017-07-28
-
Publication No.: US10934278B2Publication Date: 2021-03-02
- Inventor: Giuseppe Alvaro , Agostino Marasco , Guido Marconi
- Applicant: Autifony Therapeutics Limited
- Applicant Address: GB Stevenage
- Assignee: Autifony Therapeutics Limited
- Current Assignee: Autifony Therapeutics Limited
- Current Assignee Address: GB Stevenage
- Agency: McDermott Will & Emery LLP
- Priority: GB1613163 20160729
- International Application: PCT/GB2017/052207 WO 20170728
- International Announcement: WO2018/020263 WO 20180201
- Main IPC: C07D207/36
- IPC: C07D207/36 ; C07D207/333 ; C07D233/72 ; C07D307/94 ; C07D491/107 ; C07D405/12 ; C07C43/21 ; C07C43/196 ; C07C217/00 ; C07C69/78 ; C07C43/23 ; C07F7/18 ; C07C255/54 ; A61K45/06 ; C07C43/225 ; A61P25/00
Abstract:
The present invention provides compounds of the formula (I) and their use as Kv3 modulators.
Public/Granted literature
- US20190161479A1 NOVEL COMPOUNDS Public/Granted day:2019-05-30
Information query
